ASLAN, V. Et Al. 2022. Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.19 , 2177-2179.

ASLAN, V., SÜTCÜOĞLU, O., ÖZET, A., ÖZDEMİR, N., & YAZICI, O., (2022). Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.19, 2177-2179.

ASLAN, VOLKAN Et Al. "Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.19, 2177-2179, 2022

ASLAN, VOLKAN Et Al. "Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.19, pp.2177-2179, 2022

ASLAN, V. Et Al. (2022) . "Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.19, pp.2177-2179.

@article{article, author={VOLKAN ASLAN Et Al. }, title={Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022, pages={2177-2179} }